ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis…More, uterine fibroids, preterm labor and improving ART outcomes.
Social Media Links
REPORT RATINGS
4.8 / 5.0 (105)
ObsEva reports have an aggregate usefulness score of 4.8 based on 105 reviews.